DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Barton DL. et al.
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).
Support Care Cancer 2018;
26: 643-650
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.